The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Kindred Healthcare Inc

NYSE: KND
Last

(U.S.) $22.09

Today's change+0.15 +0.68%
Updated March 3 4:05 PM EST. Delayed by at least 15 minutes.
 

Kindred Healthcare Inc

NYSE: KND
Last

(U.S.) $22.09

Today's change+0.15 +0.68%
Updated March 3 4:05 PM EST. Delayed by at least 15 minutes.

Kindred Healthcare Inc up (U.S.)$0.15

Kindred Healthcare Inc closed up Tuesday by (U.S.)$0.15 or 0.68% to (U.S.)$22.09. Over the last five days, shares have gained 18.83% and 21.51% year to date. Shares have underperformed the S&P 500 by 13.19% during the last year.

Key company metrics

  • Open(U.S.) $21.76
  • Previous close(U.S.) $21.94
  • High(U.S.) $22.16
  • Low(U.S.) $21.42
  • Bid / Ask(U.S.) $21.70 / (U.S.) $24.99
  • YTD % change+21.51%
  • Volume1,979,734
  • Average volume (10-day)2,248,728
  • Average volume (1-month)1,692,041
  • Average volume (3-month)1,358,646
  • 52-week range(U.S.) $16.94 to (U.S.) $26.81
  • Beta2.24
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward16.48×
  • Forward PEG0.82×
  • Indicated annual dividend(U.S.) $0.48
  • Dividend yield2.17%
  • Trailing EPS(U.S.) -$0.22
Updated March 3 4:05 PM EST. Delayed by at least 15 minutes.
S&P TSX0.85%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,2431,2761,2871,195
Total other revenue--------
Total revenue1,2431,2761,2871,195
Gross profit1,1641,1951,2051,118
Total cost of revenue79818277
Total operating expense1,2121,2321,2261,235
Selling / general / administrative837851855804
Research & development--------
Depreciation / amortization39393937
Interest expense (income), net operating--------
Unusual expense (income)00076
Other operating expenses, total257261250240
Operating income314461-40
Interest income (expense), net non-operating-23-81-26-25
Gain (loss) on sale of assets--------
Other--------
Income before tax9-3436-64
Income after tax6-2122-46
Income tax, total3-1314-17
Net income-4-368-66
Total adjustments to net income0000
Net income before extra. items2-2617-48
Minority interest-4-5-5-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2-2617-48
Inc. avail. to common incl. extra. items-4-368-66
Diluted net income-4-368-66
Dilution adjustment00--0
Diluted weighted average shares63545352
Diluted EPS excluding extraordinary itemsvalue per share0.03-0.480.33-0.93
Dividends per sharevalue per share0.120.120.120.12
Diluted normalized EPSvalue per share0.03-0.480.330.02